114 related articles for article (PubMed ID: 2904450)
1. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.
Newcom SR; Kadin ME; Ansari AA; Diehl V
J Clin Invest; 1988 Dec; 82(6):1915-21. PubMed ID: 2904450
[TBL] [Abstract][Full Text] [Related]
2. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
Newcom SR; Tagra KK
Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibodies that detect Hodgkin's high molecular weight transforming growth factor-beta.
Newcom SR; Muth LH; Parker ET
Blood; 1990 Jun; 75(12):2434-7. PubMed ID: 1693533
[TBL] [Abstract][Full Text] [Related]
4. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.
Newcom SR; Kadin ME; Ansari AA
Am J Pathol; 1988 Jun; 131(3):569-77. PubMed ID: 2898211
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
Newcom SR; Gu L
J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.
Kadin M; Butmarc J; Elovic A; Wong D
Am J Pathol; 1993 Jan; 142(1):11-6. PubMed ID: 8424449
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
Newcom SR; Tagra KK; Kadin ME
Am J Pathol; 1992 Mar; 140(3):709-18. PubMed ID: 1312308
[TBL] [Abstract][Full Text] [Related]
9. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
Keski-Oja J; Lyons RM; Moses HL
Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
[TBL] [Abstract][Full Text] [Related]
10. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.
Massagué J; Kelly B
J Cell Physiol; 1986 Aug; 128(2):216-22. PubMed ID: 2874147
[TBL] [Abstract][Full Text] [Related]
11. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.
Paietta E; Racevskis J; Stanley ER; Andreeff M; Papenhausen P; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2049-55. PubMed ID: 2156611
[TBL] [Abstract][Full Text] [Related]
12. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell.
Newcom SR; Kadin ME; Phillips C
Int J Cell Cloning; 1988 Nov; 6(6):417-31. PubMed ID: 3230329
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of fibroblast growth by nodular sclerosing Hodgkin's disease cell cultures.
Newcom SR; O'Rourke L
Blood; 1982 Jul; 60(1):228-37. PubMed ID: 6211204
[TBL] [Abstract][Full Text] [Related]
14. The Hodgkin's cell in nodular sclerosis does not release interleukin-1.
Newcom SR
J Lab Clin Med; 1985 Feb; 105(2):170-7. PubMed ID: 3871830
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
16. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins.
Jennings JC; Mohan S
Endocrinology; 1990 Feb; 126(2):1014-21. PubMed ID: 2137079
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the latent transforming growth factor beta complex in bone.
Pfeilschifter J; Bonewald L; Mundy GR
J Bone Miner Res; 1990 Jan; 5(1):49-58. PubMed ID: 2309578
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
